Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice
暂无分享,去创建一个
D. Ferreira | Jerson L. Silva | F. Bozza | A. M. Gomes | Andréa C. Oliveira | S. P. C. Barroso | J. Couceiro | T. Souza | C. B. Palatnik-de-Sousa | D. Nico | D. Nascimento | A. Santos | A. M. A. Ferreira | T. M. Souza
[1] K. Subbarao,et al. Influenza , 2017, The Lancet.
[2] Sarah K White,et al. Equine Influenza A(H3N8) Virus Isolated from Bactrian Camel, Mongolia , 2014, Emerging infectious diseases.
[3] Carolina Q. Sacramento,et al. HIV-1 and Its gp120 Inhibits the Influenza A(H1N1)pdm09 Life Cycle in an IFITM3-Dependent Fashion , 2014, PloS one.
[4] D. Foguel,et al. High-pressure chemical biology and biotechnology. , 2014, Chemical reviews.
[5] D. Ferreira,et al. Full Inactivation of Human Influenza Virus by High Hydrostatic Pressure Preserves Virus Structure and Membrane Fusion While Conferring Protection to Mice against Infection , 2013, PloS one.
[6] R. Lamb,et al. Textbook of Influenza , 2013 .
[7] J. Wilschut,et al. Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100- Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies , 2013, PloS one.
[8] Ying Wu,et al. Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human , 2013, Science China Life Sciences.
[9] P. Song,et al. Changes in and shortcomings of control strategies, drug stockpiles, and vaccine development during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans. , 2013, Bioscience trends.
[10] R. Webby,et al. Host Differences in Influenza-Specific CD4 T Cell and B Cell Responses Are Modulated by Viral Strain and Route of Immunization , 2012, PloS one.
[11] F. Severcan,et al. Biophysical and microbiological study of high hydrostatic pressure inactivation of Bovine Viral Diarrheavirus type 1 on serum. , 2012, Veterinary microbiology.
[12] M. Yamashita,et al. Serial Histopathological Examination of the Lungs of Mice Infected with Influenza A Virus PR8 Strain , 2011, PloS one.
[13] Rekha Chawla,et al. High hydrostatic pressure technology in dairy processing: a review , 2011, Journal of food science and technology.
[14] Ravi S. Misra,et al. Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance , 2011, Journal of Virology.
[15] C. Sandrock,et al. Avian Influenza: Update , 2010, Medical Principles and Practice.
[16] P. Daszak,et al. Ecology of avian influenza viruses in a changing world , 2010, Annals of the New York Academy of Sciences.
[17] John Steel,et al. Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain , 2010, mBio.
[18] R. Donis,et al. Canine H3N8 Influenza Virus Infection in Dogs and Mice , 2010, Veterinary pathology.
[19] T. Tumpey,et al. Pathogenesis of Pandemic Influenza A (H1N1) and Triple-Reassortant Swine Influenza A (H1) Viruses in Mice , 2010, Journal of Virology.
[20] Z. Hantos,et al. Protective mechanical ventilation does not exacerbate lung function impairment or lung inflammation following influenza A infection. , 2009, Journal of applied physiology.
[21] R. Cox,et al. A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models , 2009, Influenza and other respiratory viruses.
[22] Katherine A. Fitzgerald,et al. Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling , 2008, PLoS pathogens.
[23] Jerson L. Silva,et al. Pressure-inactivated yellow fever 17DD virus: implications for vaccine development. , 2008, Journal of virological methods.
[24] A. Osterhaus,et al. Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus , 2008, Journal of Virology.
[25] W. Hinrichs,et al. Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities , 2008, Pharmaceutical Research.
[26] J. Wilschut,et al. Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs , 2008, Influenza and other respiratory viruses.
[27] Simon A. Jones,et al. Interleukin-6 Is Crucial for Recall of Influenza-Specific Memory CD4+ T Cells , 2008, PLoS pathogens.
[28] Shohei Koyama,et al. Differential Role of TLR- and RLR-Signaling in the Immune Responses to Influenza A Virus Infection and Vaccination , 2007, The Journal of Immunology.
[29] Y. Fujita-Yamaguchi,et al. Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine. , 2007, Vaccine.
[30] A Flahault,et al. Influenza vaccine: the challenge of antigenic drift. , 2007, Vaccine.
[31] P. Pastoret,et al. Pastoret and Gregers Jungersen Current Status of Veterinary Vaccines Current Status of Veterinary Vaccines , 2022 .
[32] Mustapha Si-Tahar,et al. Cutting Edge: Influenza A Virus Activates TLR3-Dependent Inflammatory and RIG-I-Dependent Antiviral Responses in Human Lung Epithelial Cells1 , 2007, Journal of Immunology.
[33] J. Katz,et al. Influenza: Propagation, Quantification, and Storage , 2006, Current protocols in microbiology.
[34] G. Flick,et al. Inactivation of a Norovirus by High-Pressure Processing , 2006, Applied and Environmental Microbiology.
[35] J. Woof,et al. Function of immunoglobulin A in immunity , 2000, Gut.
[36] P. Doherty,et al. Cell-mediated Protection in Influenza Infection , 2006, Emerging infectious diseases.
[37] B. Seong,et al. Antiviral effect of catechins in green tea on influenza virus. , 2005, Antiviral research.
[38] Calvin M. Johnson,et al. Transmission of Equine Influenza Virus to Dogs , 2005, Science.
[39] P. Masson,et al. The powerful high pressure tool for protein conformational studies. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[40] K. Calci,et al. High-Pressure Inactivation of Hepatitis A Virus within Oysters , 2005, Applied and Environmental Microbiology.
[41] I. Capua,et al. Avian influenza: recent developments , 2004, Avian pathology : journal of the W.V.P.A.
[42] J. Piercy,et al. Immunogenicity and protective efficacy of influenza vaccination. , 2004, Virus research.
[43] J. Johnson,et al. Virus stability and protein-nucleic acid interaction as studied by high-pressure effects on nodaviruses. , 2004, Cellular and molecular biology.
[44] Hamilton Moreira,et al. Avaliação espectrofotométrica do azul de Evans na reação inflamatória da córnea: estudo experimental em coelhos , 2004 .
[45] M. van Egmond,et al. The Fc receptor for IgA (FcalphaRI, CD89). , 2004, Immunology letters.
[46] R. Cox,et al. Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines , 2004, Scandinavian journal of immunology.
[47] M. Egmond,et al. Chapter 2 The Fc receptor for IgA (FcαRI, CD89) , 2004 .
[48] Jerson L. Silva,et al. Pressure-induced fusogenic conformation of vesicular stomatitis virus glycoprotein. , 2003, Biochemistry.
[49] J. Silva,et al. Inactivation of classical swine fever virus: association of hydrostatic pressure and ultraviolet irradiation. , 2003, Journal of virological methods.
[50] E. Neumeier,et al. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines , 2002, Medical Microbiology and Immunology.
[51] K. Subbarao,et al. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. , 2002, Emerging infectious diseases.
[52] T. Di Pucchio,et al. Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model1 , 2002, The Journal of Immunology.
[53] D. Clark,et al. Pressure effects on intra- and intermolecular interactions within proteins. , 2002, Biochimica et biophysica acta.
[54] M. Lamm,et al. Origin and Homing of Intestinal IgA Antibody-secreting Cells , 2002, The Journal of experimental medicine.
[55] Uenza Manu. WHO Manual on Animal Influenza Diagnosis and Surveillance , 2002 .
[56] C A Royer,et al. Pressure provides new insights into protein folding, dynamics and structure. , 2001, Trends in biochemical sciences.
[57] J. Aucouturier,et al. Adjuvants designed for veterinary and human vaccines. , 2001, Vaccine.
[58] P. Masson,et al. High-pressure biotechnology in medicine and pharmaceutical science , 2001, Journal of biomedicine & biotechnology.
[59] A. Stack,et al. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice , 2000, Journal of medical virology.
[60] C. Balny,et al. Effects of hydrostatic pressure on the structure and biological activity of infectious bursal disease virus. , 2000, European journal of biochemistry.
[61] Marjolein van Egmond,et al. FcαRI-positive liver Kupffer cells: Reappraisal of the function of immunoglobulin A in immunity , 2000, Nature Medicine.
[62] K. Van Reeth. Cytokines in the pathogenesis of influenza. , 2000, Veterinary microbiology.
[63] A. Fernández-Sesma,et al. Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. , 1999, The Journal of infectious diseases.
[64] R. Webster,et al. Protection against a Lethal Avian Influenza A Virus in a Mammalian System , 1999, Journal of Virology.
[65] Tian Shao-min,et al. High Immunogenicity of the Pressure-inactivated Virus. , 1999 .
[66] K. Ruan,et al. High Immunogenicity of the Pressure-inactivated Virus. , 1999, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica.
[67] K. Heremans,et al. Protein structure and dynamics at high pressure. , 1998, Biochimica et biophysica acta.
[68] A. Hoffman,et al. Techniques for sampling the respiratory tract of horses. , 1997, The Veterinary clinics of North America. Equine practice.
[69] P. Prevelige,et al. The use of hydrostatic pressure as a tool to study viruses and other macromolecular assemblages. , 1996, Current opinion in structural biology.
[70] B. Mahy,et al. Virology methods manual , 1996 .
[71] G. Weber,et al. Inactivation of simian immunodeficiency virus by hydrostatic pressure. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[72] G. Weber,et al. Effects of hydrostatic pressure on a membrane-enveloped virus: high immunogenicity of the pressure-inactivated virus , 1992, Journal of virology.
[73] C. Naeve,et al. Antigenic and genetic conservation of H3 influenza virus in wild ducks. , 1987, Virology.
[74] G. Warr,et al. Alveolitis induced by influenza virus. , 1983, The American review of respiratory disease.
[75] D. Ingram,et al. The relationship of genotype, sex, body weight, and growth parameters to lifespan in inbred and hybrid mice , 1982, Mechanisms of Ageing and Development.
[76] R. Webster,et al. Failure to Detect Hemagglutination-Inhibiting Antibodies with Intact Avian Influenza Virions , 1982, Infection and immunity.
[77] G. Weber,et al. Pressure-induced reversible dissociation of enolase. , 1981, Biochemistry.
[78] G. Peterson,et al. Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall. , 1979, Analytical biochemistry.
[79] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[80] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .